Test Price
2,800 AED✅ Home Collection Available
COX4I2 Gene Genetic Test – Exocrine Pancreatic Insufficiency, Dyserythropoietic Anemia & Calvarial Hyperostosis in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين COX4I2 بتقنية التسلسل الجيني (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
✅ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
🚑 Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold‑Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM daily).
📞 Clinical Guidance: Telephonic Post‑Test Clinical Guidance session with a qualified genetic counsellor to interpret results.
💳 Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
هذا الفحص الجيني المتطور يكشف الطفرات المسببة لقصور البنكرياس الإفرازي، فقر الدم المكون للكريات الحمراء، وفرط التعظم القحفي المرتبطة بجين COX4I2. جميع الخدمات مطابقة لقانون دولة الإمارات العربية المتحدة الاتحادي رقم 41 لسنة 2024 وقانون حماية البيانات الشخصية.
Clinical Overview
The COX4I2 Gene NGS Test is a comprehensive next‑generation sequencing analysis that detects pathogenic variants in the entire coding region of the COX4I2 gene, responsible for a rare syndromic triad: exocrine pancreatic insufficiency, congenital dyserythropoietic anemia, and calvarial hyperostosis.
اختبار تحليل جين COX4I2 هو فحص تسلسلي كامل للطفرات المسببة لمتلازمة نادرة تجمع بين قصور البنكرياس الإفرازي وفقر الدم الخلقي وزيادة سُمْك عظام الجمجمة.
Test Method Comparison
| Feature | Our Test: COX4I2 NGS | Alternative: Single‑Variant PCR |
|---|---|---|
| Methodology | NGS (Next Generation Sequencing) – full gene coverage | PCR for known single‑nucleotide variants only |
| Detection Rate | >99.9% sensitivity for coding and splice‑site variants | Limited to pre‑specified mutations; misses novel variants |
| Turnaround Time | 3–4 Weeks | 2–3 Weeks (if targeted) |
| Price | 2800 AED (inclusive of counselling) | Variable, often 1500–2000 AED (limited coverage) |
| Accreditation | ISO 9001:2015 – DHA‑Licensed Facility (9834453) | May vary; often without comprehensive counselling |
Physician Insight & Safety Protocol
"A positive COX4I2 result is not a diagnosis in isolation; clinical correlation with haematological, gastrointestinal, and bone imaging findings is essential. I strongly recommend pre‑ and post‑test genetic counselling to interpret the variant's significance for your health and family planning. — Dr. PRABHAKAR REDDY, DHA License 61713011"
⚠️ Medication Safety Notice
Do not discontinue any prescribed medication (e.g., pancreatic enzymes, iron chelators, bone‑modifying agents) without explicit consultation with your treating physician. Genetic testing does not replace ongoing clinical management.
🛑 Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients who decline mandatory pre‑test genetic counselling; minors without legal guardian consent (per UAE CDS Law 2026); inability to provide a viable DNA sample.
- Emergency Red Flags: Acute severe abdominal pain, signs of acute pancreatitis, acute hemolytic crisis, or sudden worsening of bone pain/swelling require immediate emergency medical evaluation, not delay for genetic testing.
Patient FAQ & Clinical Guidance
Q: What symptoms does the COX4I2 gene test help explain?
Snippet: This test identifies mutations causing a syndrome that combines pancreatic insufficiency, anemia, and skull bone thickening.
Clinically, the COX4I2 gene panel clarifies the genetic aetiology of a complex multisystem disorder characterised by fat malabsorption, dyserythropoietic anemia, and progressive calvarial hyperostosis. Early molecular diagnosis enables personalised surveillance and management of endocrine, haematological, and skeletal complications.
Q: How long does it take to receive my results, and will a doctor explain them?
Snippet: Results are available in 3 to 4 weeks and include a telephonic consultation with a genetic counsellor.
After your ISO‑accredited sample processing, a confidential report is released within 3–4 weeks. You will receive a scheduled post‑ clinical guidance call to interpret the findings, discuss implications for family members, and plan further medical steps, ensuring you are never left alone with raw data.
س: هل الاختبار معتمد بموجب قوانين دولة الإمارات لحماية البيانات؟
ملخص سريع: نعم، جميع إجراءاتنا متوافقة مع قانون حماية البيانات الشخصية وقانون مكافحة المواد المخدرة والخدمات الصحية للأحداث 2026.
نحن نلتزم التزامًا كاملاً بالمرسوم الاتحادي بقانون رقم 41 لسنة 2024، وقانون مراقبة الأدوية والمؤثرات العقلية لسنة 2026 (للأحداث)، وسياسة الخصوصية الصحية في الإمارات. يتم جمع العينات بموافقة مستنيرة كاملة، وتخزين البيانات في خوادم معتمدة داخل الدولة، ولا تُشارك المعلومات مع أي طرف خارجي دون تفويض قضائي.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians